These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12788642)

  • 1. The molecular basis of the antigenic cross-reactivity between measles and cowpea mosaic viruses.
    Olszewska W; Steward MW
    Virology; 2003 May; 310(1):183-9. PubMed ID: 12788642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.
    Obeid OE; Partidos CD; Howard CR; Steward MW
    J Virol; 1995 Mar; 69(3):1420-8. PubMed ID: 7531779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W; Obeid OE; Steward MW
    Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response.
    Steward MW; Stanley CM; Obeid OE
    J Virol; 1995 Dec; 69(12):7668-73. PubMed ID: 7494275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.
    Atabani SF; Obeid OE; Chargelegue D; Aaby P; Whittle H; Steward MW
    J Virol; 1997 Oct; 71(10):7240-5. PubMed ID: 9311797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies.
    Ziegler D; Fournier P; Berbers GA; Steuer H; Wiesmüller KH; Fleckenstein B; Schneider F; Jung G; King CC; Muller CP
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2479-89. PubMed ID: 8887481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression & immunogenicity of malaria merozoite peptides displayed on the small coat protein of chimaeric cowpea mosaic virus.
    Yasawardene SG; Lomonossoff GP; Ramasamy R
    Indian J Med Res; 2003 Sep; 118():115-24. PubMed ID: 14700344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen.
    Hathaway LJ; Obeid OE; Steward MW
    Vaccine; 1998; 16(2-3):135-41. PubMed ID: 9607021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis.
    El Kasmi KC; Theisen D; Brons NH; Ammerlaan W; Klingele M; Truong AT; Muller CP
    Vaccine; 1999 May; 17(19):2436-45. PubMed ID: 10392626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice.
    de Vries P; van Binnendijk RS; van der Marel P; van Wezel AL; Voorma HO; Sundquist B; Uytdehaag FG; Osterhaus AD
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():549-59. PubMed ID: 3258355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies.
    El Kasmi KC; Fillon S; Theisen DM; Hartter H; Brons NH; Muller CP
    J Gen Virol; 2000 Mar; 81(Pt 3):729-35. PubMed ID: 10675410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model.
    Partidos CD; Ripley J; Delmas A; Obeid OE; Denbury A; Steward MW
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3227-32. PubMed ID: 9400973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of human antibody to the fusion protein of measles virus.
    Sato TA; Kohama T; Sugiura A
    Microbiol Immunol; 1989; 33(7):601-7. PubMed ID: 2671610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.
    Varsanyi TM; Morein B; Löve A; Norrby E
    J Virol; 1987 Dec; 61(12):3896-901. PubMed ID: 2960833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus.
    Obeid OE; Stanley CM; Steward MW
    Virus Res; 1996 Jun; 42(1-2):173-80. PubMed ID: 8806185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein.
    El Kasmi KC; Theisen D; Brons NH; Muller CP
    Mol Immunol; 1998 Oct; 35(14-15):905-18. PubMed ID: 9881686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of antibody response to synthetic peptides derived from the fusion protein of measles virus.
    Meqdam M; Mostratos A
    New Microbiol; 1999 Jan; 22(1):19-25. PubMed ID: 10190113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
    Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
    J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies.
    de Swart RL; Yüksel S; Langerijs CN; Muller CP; Osterhaus ADME
    J Gen Virol; 2009 Dec; 90(Pt 12):2982-2989. PubMed ID: 19710253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis.
    Fournier P; Brons NH; Berbers GA; Wiesmüller KH; Fleckenstein BT; Schneider F; Jung G; Muller CP
    J Gen Virol; 1997 Jun; 78 ( Pt 6)():1295-302. PubMed ID: 9191921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.